German medical technology company Brainlab has acquired application-specific robotic technologies developer Medineering in order to boost its digital surgery solutions portfolio.

The deal expands Brainlab cranial surgery and spinal surgery portfolio. The company currently markets Medineering’s intuitive surgical assistant division called Cirq to more than 4,000 of its existing customers.

A combination of base arm and attachable hand modules, Cirq is adaptable and enables freedom for maximum positioning flexibility.

It can be used as a standard instrument holder, as well as for holding robotic hands to align biopsy needles, drill guides and endoscopes.

Brainlab president and CEO Stefan Vilsmeier said: “Medineering introduced a fresh new approach to surgical robotics when we entered into our partnership less than three years ago.

“Combining our open platform with the software ecosystem from Brainlab will enable more efficient development of very competitive clinical solutions.”

“Today, we are shifting gears and accelerating development with additional resources to address a broader clinical market.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Brainlab noted that the acquisition adds a new platform to the open hardware architecture of its digital ecosystem for surgery, allowing other medical technology firms to design their own products for different subspecialties.

The deal is also expected to provide an open platform for a variety of clinical opportunities.

Medineering co-founder and CEO Stephan Nowatschin added: “Becoming part of Brainlab means scalability for our technology and improved market access.

“Combining our open platform with the software ecosystem from Brainlab will enable more efficient development of very competitive clinical solutions.”

Early this month, Brainlab has agreed to sell its orthopaedic joint reconstruction business to UK-based medical technology company Smith & Nephew.

Brainlab’s orthopaedic joint reconstruction business offers surgical digital workflow tools, including solutions for pre-operative planning, intraoperative navigation, postoperative evaluation and sharing.

The acquisition also covers some intangible assets and the orthopaedic Brainlab salesforce, which will become part of the Smith & Nephew robotics commercial organisation.